Beranda › Kolitis Ulseratif
Uji klinis Kolitis Ulseratif yang merekrut di AS
80 studi untuk Kolitis Ulseratif merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY24 studi
- Orlando, FL23 studi
- Miami, FL22 studi
- Houston, TX18 studi
- San Antonio, TX16 studi
- Tacoma, WA15 studi
- Chicago, IL15 studi
- San Diego, CA15 studi
- Colorado Springs, CO14 studi
- St. Louis, MO14 studi
- Tyler, TX14 studi
- Los Angeles, CA13 studi
- Boston, MA12 studi
- Washington, DC12 studi
- Durham, NC11 studi
- Providence, RI11 studi
- Cincinnati, OH11 studi
- Louisville, KY10 studi
- Tampa, FL10 studi
- Parma, OH10 studi
- Lewisville, TX10 studi
- Atlanta, GA9 studi
- Lubbock, TX9 studi
- Evanston, IL9 studi
- Seattle, WA8 studi
- Scottsdale, AZ8 studi
- Round Rock, TX8 studi
- Lancaster, CA8 studi
- Mountain View, CA8 studi
- Dallas, TX8 studi
- Baltimore, MD8 studi
- Memphis, TN8 studi
- Cleveland, OH8 studi
- Metairie, LA8 studi
- Garland, TX8 studi
- Charlotte, NC7 studi
- Waukegan, IL7 studi
- Pittsburgh, PA7 studi
- Wyoming, MI7 studi
- Fort Worth, TX7 studi
Berdasarkan negara bagian
- Alabama7 studi
- Arizona19 studi
- Arkansas4 studi
- California40 studi
- Colorado17 studi
- Connecticut11 studi
- Distrik Columbia3 studi
- Florida32 studi
- Georgia15 studi
- Idaho4 studi
- Illinois24 studi
- Indiana9 studi
- Iowa3 studi
- Kansas10 studi
- Kentucky13 studi
- Louisiana15 studi
- Maryland13 studi
- Massachusetts17 studi
- Michigan17 studi
- Minnesota8 studi
- Mississippi6 studi
- Missouri17 studi
- Nevada6 studi
- New Hampshire5 studi
- New Jersey7 studi
- New York31 studi
- North Carolina24 studi
- Ohio26 studi
- Oklahoma4 studi
- Oregon5 studi
- Pennsylvania13 studi
- Rhode Island11 studi
- South Carolina12 studi
- South Dakota4 studi
- Tennessee12 studi
- Texas34 studi
- Utah8 studi
- Virginia14 studi
- Washington22 studi
- Wisconsin4 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07697456Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Menerima pesertaStudi observasional
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07619547A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Menerima pesertaFase 4
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06581328Confirmatory Clinical Study in Active Ulcerative Colitis
Menerima pesertaFase 2
Usia 16 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07296315A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07071519A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07845487Immune Regulation in Ulcerative Colitis or Crohn s Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Day – 75 Years · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00001184A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07463183A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Menerima pesertaFase 3
Usia 3 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Menerima pesertaFase 2/3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Menerima pesertaFase 3
Usia 2 hingga 19 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04844606LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Menerima pesertaFase 4
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06095128Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07513181A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 3
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07185009Microbiome-targeted Diet Therapy in Ulcerative Colitis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07520461Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.